The Pharma & Biotech market had a relatively positive month with 41.5% of the coverage universe posting positive share price ...

The U.S. health regulator has declined to approve Zealand Pharma's drug to prevent and treat low blood sugar in children with ...

Zealand Pharma said it has received a complete response letter from the Food and Drug Administration related to its new drug application for dasiglucagon for the prevention and treatment of ...

Denmark's Zealand Pharma said on Tuesday the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) relating to its drug for preventing and treating low blood sugar in ...

Christian Kettel Thomsen: The inflation job is basically done in Denmark after a series of unprecedented shocks led to ...

Norstella LinQ establishes a throughline between the company’s various subsidiaries, utilizing capabilities from Citeline, ...

In another blow to its $525 million buyout of ReViral, Pfizer has ended development of sisunatovir, an oral inhibitor ...

Aviadobio Ltd. has entered a potential $2.18 billion license and commercialization agreement for its frontotemporal dementia gene therapy, AVB-101, with Astellas Pharma Inc. Astellas is making a $20 ...

Dishant Gupta, a former pharma executive from N.J., pled guilty to insider trading and could face up to 20 years in prison.

Is your company bracing for Milton or working to provide aid in anticipation of the storm? | Pfizer—which opened a global hub ...

Everybody loves finding a bargain or getting a good deal, and it's no different when it comes to stocks. One of the most popular technical indicators for helping investors find these is the Relative ...

For the pharma industry, the report highlights ways in which it can be a partner in healthcare innovation and support the NHS.